Apolipoprotein E is associated with blood lipids and inflammation in Taiwanese older adults

Atherosclerosis

Volumn 219, Issue 1, 2011, Pages 349-354

  Vasunilashorn, Sarinnapha ^a   Glei, Dana A ^b   Lan, Chia Ying ^c   Brookmeyer, Ron ^d   Weinstein, Maxine ^b   Goldman, Noreen ^a  

^a PRINCETON UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c Department of Health   (Taiwan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apolipoprotein E; C reactive protein; Cholesterol; Mortality

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LIPID BLOOD LEVEL; LONGEVITY; MALE; MORTALITY; PRIORITY JOURNAL; TAIWAN;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INFLAMMATION; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SURVIVAL ANALYSIS; TAIWAN;

EID: 81155160912     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.07.100     Document Type: Article

References (41)

1. Mahley R. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
2. Corder E., Saunders A., Strittmatter W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
3. Eichner J.E., Dunn S.T., Perveen G., et al. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002, 155:487-495.
4. Dufouil C., Richard F., Fiévet N., et al. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia. Neurology 2005, 64:1531-1538.
5. Ewbank D.C., Olshansky S.J. The APOE gene and differences in life expectancy in Europe. J Gerontol A Biol Sci Med Sci 2004, 59:16-20.
6. Ewbank D.C. Differences in the association between apolipoprotein E genotype and mortality across populations. J Gerontol A Biol Sci Med Sci 2007, 62A:899-907.
7. Schachter F., Faure-DiDelanef L., Guenot F., et al. Genetic associations with human longevity at the APOE and ACE loci. Nature Genet 1994, 6:29-32.
8. Rebeck G.W., Kindy M., LaDu M.J. Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and ApoE3. J Alzheimers Dis 2002, 4:145-154.
9. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytoxicity by oxidative insults and beta-amyloid peptides. Nature Genet 1996, 14:55-61.
10. Ewbank D.C. Mortality differences by APOE genotype estimated from demographic synthesis. Genet Epidemiol 2002, 22:146-155.
11. Davignon J., Gregg R., Sing C. Apolipoprotein E polymorphism and atherosclerosis. Arterioscler Thromb Vasc Biol 1988, 8:1-21.
12. Pouliot M.C., Després J.P., Moorjani S., et al. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women. J Lipid Res 1990, 31:1023-1029.
13. Eiriksdottir G., Aspelund T., Bjarnadottir K., et al. Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study. Atherosclerosis 2006, 186:222-224.
14. Olgiati P., Politis A., Malitas P., et al. APOE epsilon-4 allele and cytokine production in Alzheimer's disease. Int J Geriatr Psychiatry 2010, 25:338-344.
15. Gerdes L.U., Jeune B., Ranberg K.A., et al. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: Apolipoprotein E gene is a frailty gene, not a longevity gene. Genet Epidemiol 2000, 19:202-210.
16. Hayden K.M., Zandi P.P., Lyketsos C.G., et al. Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc 2005, 53:935-942.
17. Niu W., Guo X., Su Y., et al. Apolipoprotein E and low-density lipoprotein receptor gene polymorphisms in dyslipidemias-associated essential hypertension. J Hum Hypertens 2007, 21:337-339.
18. Tan C.E., Tai E.S., Tan C.S., et al. APOE polymorphism and lipid profile in three ethnic groups in the Singapore population. Atherosclerosis 2003, 170:253-260.
19. Goldman N., Lin I., Weinstein M., et al. Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol 2003, 56:148-154.
20. Chang M., Glei D., Goldman N., et al. Biosocial Surveys. The Taiwan Biomarker Project 2007, 60-77. National Academies Press, Washington, DC. M. Weinstein, J.W. Vaupel, K.W. Wachter (Eds.).
21. Glei D.A., Goldman N., Lin Y.H., et al. Age-related changes in biomarkers: longitudinal data from a population-based sample. J Clin Epidemiol 2011, 33:312-326.
22. Gustincich S., Manfioletti G., Del Sal G., et al. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991, 11:298-300.
23. Goldman N., Weinstein M., Lin H., et al. 2000 Social Environment and Biomarkers of Aging study in Taiwan (SEBAS): Main Documentation for SEBAS Public Use Data 2003, Inter-University Consortium for Political and Social Research, Ann Arbor.
24. Crimmins E., Vasunilashorn S., Kim J.K., et al. Biomarkers related to aging in human populations. Adv Clin Chem 2008, 46:161-216.
25. Adult Treatment Panel III. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Institutes of Health; 2001.
26. Horiuchi S., Coale A.J. A simple equation for estimating the expectation of life at old ages. Popul Stud 1982, 36:317-326.
27. Wang K.Q., He J.L., Xie Y.H. Studies of human apolipoprotein E genetic isoforms and their phenotypes among the Chinese population. Proc Chin Acad Sci Peking Union Med Coll 1987, 2:133-139.
28. Lahoz C., Schaefer E.J., Cupples L.A., et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 2001, 154:529-537.
29. Sing C., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985, 37:268-285.
30. Rontu R., Ojala P., Hervonen A., et al. Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians. Clin Endocrinol 2006, 64:265-270.
31. März W., Scharnagl H., Hoffmann M.M., et al. The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). Eur Heart J 2004, 25:2109-2119.
32. Jialal I., Stein D., Balis D., et al. Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 2001, 103:1933-1935.
33. Austin M.A., Zhang C., Humphries S.E., et al. Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans. Ann Hum Genet 2004, 68:179-188.
34. Weisgraber K.H., Innerarity T.L., Mahley R.W. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 1982, 257:2518-2521.
35. Hatters D.M., Peters-Libeu C.A., Weisgraber K.H. Apolipoprotein E structure: insights into function. Trends Biochem Sci 2006, 31:445-454.
36. Bennet A.M., Prince J.A., Fei G., et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 2003, 171:359.
37. Wang M., Jia J. The interleukin-6 gene -572C/G promoter polymorphism modifies Alzheimer's risk in APOE e{open}4 carriers. Neurosci Lett 2010, 482:260-263.
38. Baune B.T., Ponath G., Rothermundt M., et al. Association between genetic variants of IL-1β, IL-6 and TNF-α cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology 2008, 33:68-76.
39. Arvidson N.G., Gudbjörnsson B., Elfman L., et al. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheumat Dis 1994, 53:521-524.
40. Fillenbaum G.G., Blazer D.G., Burchett B.M., et al. Apolipoprotein E e{open}4 and risk of mortality in African American and white older community residents. Gerontologist 2002, 42:381-386.
41. Lee J.H., Tang M., Schupf N., et al. Mortality and Apolipoprotein E in Hispanic, African-American, and Caucasian elders. Am J Med Genet 2001, 103:121-127.